These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 11692082)

  • 21. The ABCB1-1Delta mutation is not responsible for subchronic neurotoxicity seen in dogs of non-collie breeds following macrocyclic lactone treatment for generalized demodicosis.
    Bissonnette S; Paradis M; Daneau I; Silversides DW
    Vet Dermatol; 2009 Feb; 20(1):60-6. PubMed ID: 19152588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Canine ABCB1 and macrocyclic lactones: heartworm prevention and pharmacogenetics.
    Mealey KL
    Vet Parasitol; 2008 Dec; 158(3):215-22. PubMed ID: 18922637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breed distribution of the nt230(del4) MDR1 mutation in dogs.
    Gramer I; Leidolf R; Döring B; Klintzsch S; Krämer EM; Yalcin E; Petzinger E; Geyer J
    Vet J; 2011 Jul; 189(1):67-71. PubMed ID: 20655253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic implications of the MDR-1 gene.
    Mealey KL
    J Vet Pharmacol Ther; 2004 Oct; 27(5):257-64. PubMed ID: 15500562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Canine mdr1 gene mutation in Japan.
    Kawabata A; Momoi Y; Inoue-Murayama M; Iwasaki T
    J Vet Med Sci; 2005 Nov; 67(11):1103-7. PubMed ID: 16327220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of ABCB1 genotype in Collies on the pharmacokinetics of R- and S-fexofenadine.
    Myers MJ; Martinez M; Li F; Howard K; Yancy HF; Troutman L; Sharkey M
    J Vet Pharmacol Ther; 2018 Dec; 41(6):805-814. PubMed ID: 30020547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Canine and feline P-glycoprotein deficiency: What we know and where we need to go.
    Mealey KL; Owens JG; Freeman E
    J Vet Pharmacol Ther; 2023 Jan; 46(1):1-16. PubMed ID: 36326478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haplotype analysis of the MDR1 flanking region in the dog breed Elo.
    Fecht S; Wöhlke A; Distl O
    Berl Munch Tierarztl Wochenschr; 2008; 121(5-6):211-5. PubMed ID: 18557525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain penetration of ivermectin and selamectin in mdr1a,b P-glycoprotein- and bcrp- deficient knockout mice.
    Geyer J; Gavrilova O; Petzinger E
    J Vet Pharmacol Ther; 2009 Feb; 32(1):87-96. PubMed ID: 19161460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the canine mdr1-1Delta mutation in the dog breed Elo.
    Fecht S; Wöhlke A; Hamann H; Distl O
    J Vet Med A Physiol Pathol Clin Med; 2007 Oct; 54(8):401-5. PubMed ID: 17877579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ivermectin: does P-glycoprotein play a role in neurotoxicity?
    Edwards G
    Filaria J; 2003 Oct; 2 Suppl 1(Suppl 1):S8. PubMed ID: 14975065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of the
    Nürnberger D; Wagner L; Müller SF; Leiting S; Leidolf R; Alber J; Hamann M; Geyer J
    Front Vet Sci; 2021; 8():808392. PubMed ID: 35265692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the MDR1 gene and P-glycoprotein in canine mast cell tumor cell lines.
    Nakaichi M; Takeshita Y; Okuda M; Nakamoto Y; Itamoto K; Une S; Sasaki N; Kadosawa T; Takahashi T; Taura Y
    J Vet Med Sci; 2007 Feb; 69(2):111-5. PubMed ID: 17339753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog.
    Xu M; Molento M; Blackhall W; Ribeiro P; Beech R; Prichard R
    Mol Biochem Parasitol; 1998 Mar; 91(2):327-35. PubMed ID: 9566525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical observations in collies given ivermectin orally.
    Paul AJ; Tranquilli WJ; Seward RL; Todd KS; DiPietro JA
    Am J Vet Res; 1987 Apr; 48(4):684-5. PubMed ID: 3592367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetics: it's not just about ivermectin in collies.
    Dowling P
    Can Vet J; 2006 Dec; 47(12):1165-8. PubMed ID: 17217086
    [No Abstract]   [Full Text] [Related]  

  • 37. Frequency of the MDR1 mutant allele associated with multidrug sensitivity in dogs from Brazil.
    Monobe MM; Junior JPA; Lunsford KV; Silva RC; Bulla C
    Vet Med (Auckl); 2015; 6():111-117. PubMed ID: 30101099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.
    Zhou SF
    Xenobiotica; 2008 Jul; 38(7-8):802-32. PubMed ID: 18668431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of the nt230[del4] MDR1 mutation in dogs by a fluorogenic 5' nuclease TaqMan allelic discrimination method.
    Klintzsch S; Meerkamp K; Döring B; Geyer J
    Vet J; 2010 Sep; 185(3):272-7. PubMed ID: 19733104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of dermal application of 10.0% imidacloprid-0.08% ivermectin in ivermectin-sensitive Collies.
    Paul AJ; Hutchens DE; Firkins LD; Keehan CM
    Am J Vet Res; 2004 Mar; 65(3):277-8. PubMed ID: 15027671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.